0.3577
price up icon2.05%   0.0072
 
loading
Precedente Chiudi:
$0.3505
Aprire:
$0.36
Volume 24 ore:
131.09K
Relative Volume:
0.75
Capitalizzazione di mercato:
$16.47M
Reddito:
-
Utile/perdita netta:
$-74.56M
Rapporto P/E:
-0.1953
EPS:
-1.8316
Flusso di cassa netto:
$-60.27M
1 W Prestazione:
+9.69%
1M Prestazione:
+8.62%
6M Prestazione:
-61.12%
1 anno Prestazione:
-74.45%
Intervallo 1D:
Value
$0.348
$0.37
Intervallo di 1 settimana:
Value
$0.30
$0.3796
Portata 52W:
Value
$0.2201
$1.54

Rallybio Corp Stock (RLYB) Company Profile

Name
Nome
Rallybio Corp
Name
Telefono
203- 859-3820
Name
Indirizzo
234 CHURCH STREET, NEW HAVEN
Name
Dipendente
24
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
RLYB's Discussions on Twitter

Confronta RLYB con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
RLYB
Rallybio Corp
0.3577 16.47M 0 -74.56M -60.27M -1.8316
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.82 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
519.23 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
316.63 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
558.50 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
259.28 28.51B 3.81B -644.79M -669.77M -6.24

Rallybio Corp Stock (RLYB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-09 Downgrade H.C. Wainwright Buy → Neutral
2024-05-15 Downgrade JP Morgan Overweight → Neutral
2024-02-07 Downgrade Jefferies Buy → Hold
2023-04-17 Iniziato H.C. Wainwright Buy
2023-04-10 Iniziato Wedbush Outperform
2022-12-09 Iniziato JP Morgan Overweight
2022-02-22 Iniziato JMP Securities Mkt Outperform
2021-08-23 Iniziato Cowen Outperform
2021-08-23 Iniziato Evercore ISI Outperform
2021-08-23 Iniziato Jefferies Buy
Mostra tutto

Rallybio Corp Borsa (RLYB) Ultime notizie

pulisher
Jun 13, 2025

Affibody’s licensee Rallybio Announces Initiation of Dosing with RLYB116 in Phase 1 Confirmatory PK/PD Study - TradingView

Jun 13, 2025
pulisher
Jun 12, 2025

Rallybio begins dosing in phase 1 study of C5 inhibitor RLYB116 By Investing.com - Investing.com South Africa

Jun 12, 2025
pulisher
Jun 12, 2025

Rallybio Initiates Dosing in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study - BioSpace

Jun 12, 2025
pulisher
Jun 12, 2025

Rallybio begins dosing in phase 1 study of C5 inhibitor RLYB116 - Investing.com India

Jun 12, 2025
pulisher
Jun 12, 2025

Rallybio Initiates Dosing In RLYB116 Phase 1 Confirmatory Study - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Rallybio's $5B Market Opportunity: New Phase 1 Trial Targets Two Untreated Rare Blood Disorders - Stock Titan

Jun 12, 2025
pulisher
Jun 03, 2025

RLYBRallybio Announces Initiation of Dosing in RLYB212 Phase 2 Clinical Trial - mx.advfn.com

Jun 03, 2025
pulisher
May 27, 2025

Connecticut biotech shows resilience amid recent layoffs at Arvinas, RallyBio - Trumbull Times

May 27, 2025
pulisher
May 23, 2025

Rallybio’s SWOT analysis: C5 inhibitor focus shifts stock outlook By Investing.com - Investing.com Canada

May 23, 2025
pulisher
May 22, 2025

Rallybio’s SWOT analysis: C5 inhibitor focus shifts stock outlook - Investing.com

May 22, 2025
pulisher
May 17, 2025

Rallybio shareholders elect directors, ratify auditor By Investing.com - Investing.com Nigeria

May 17, 2025
pulisher
May 16, 2025

Rallybio shareholders elect directors, ratify auditor - Investing.com

May 16, 2025
pulisher
May 16, 2025

Rallybio Elects New Directors at Shareholder Meeting - TipRanks

May 16, 2025
pulisher
May 14, 2025

Rallybio Reports Q1 2025 Financial Results and Strategic Updates - MSN

May 14, 2025
pulisher
May 09, 2025

New Haven biotech firm to cut 40% of workforce in latest round of layoffs, pivots on drug program - Stamford Advocate

May 09, 2025
pulisher
May 09, 2025

Rallybio Downsizes by 40% After Dropping Lead Asset - BioSpace

May 09, 2025
pulisher
May 09, 2025

Layoffs hit biotech: Vor Bio slashes 95% of staff, more cuts from insitro, Korro, Rallybio - FirstWord Pharma

May 09, 2025
pulisher
May 08, 2025

4 more biotechs cut staff amid market tumult - BioPharma Dive

May 08, 2025
pulisher
May 08, 2025

Rallybio Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

Another CT biotech company making significant workforce cuts - Hartford Business Journal

May 08, 2025
pulisher
May 08, 2025

RallyBio cuts deeper, laying off 40% of workforce after halting work on lead drug - Fierce Biotech

May 08, 2025
pulisher
May 08, 2025

Rallybio Corp SEC 10-Q Report - TradingView

May 08, 2025
pulisher
May 08, 2025

Rallybio Reports First Quarter 2025 Financial Results and Provides Business Updates - Bluefield Daily Telegraph

May 08, 2025
pulisher
May 07, 2025

Rallybio (RLYB) to Release Quarterly Earnings on Thursday - Defense World

May 07, 2025
pulisher
May 05, 2025

Renaissance Technologies LLC Has $424,000 Stock Position in Rallybio Co. (NASDAQ:RLYB) - Defense World

May 05, 2025
pulisher
Apr 30, 2025

Rallybio to Present at the 2025 Citizens JMP Life Sciences Conference - BioSpace

Apr 30, 2025
pulisher
Apr 29, 2025

Rallybio Makes Nasdaq Debut - RTTNews

Apr 29, 2025
pulisher
Apr 23, 2025

Citizens JMP maintains Rallybio stock at Market Perform By Investing.com - Investing.com Nigeria

Apr 23, 2025
pulisher
Apr 23, 2025

Citizens JMP maintains Rallybio stock at Market Perform - Investing.com

Apr 23, 2025
pulisher
Apr 16, 2025

Rallybio (NASDAQ:RLYB) Cut to Hold at Evercore ISI - Defense World

Apr 16, 2025
pulisher
Apr 15, 2025

Rallybio drops drug for rare maternal disorder following Phase II fail - MSN

Apr 15, 2025
pulisher
Apr 15, 2025

This General Motors Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga

Apr 15, 2025
pulisher
Apr 14, 2025

Evercore ISI Downgrades Rallybio to In Line From Outperform - marketscreener.com

Apr 14, 2025
pulisher
Apr 13, 2025

Analysts Set Rallybio Co. (NASDAQ:RLYB) Price Target at $9.75 - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

Evercore ISI cuts Rallybio stock rating on study concerns - Investing.com Australia

Apr 12, 2025
pulisher
Apr 12, 2025

HC Wainwright Estimates Rallybio’s Q2 Earnings (NASDAQ:RLYB) - Defense World

Apr 12, 2025
pulisher
Apr 12, 2025

Rallybio’s (RLYB) Neutral Rating Reiterated at HC Wainwright - Defense World

Apr 12, 2025
pulisher
Apr 11, 2025

Evercore ISI cuts Rallybio stock rating on study concerns By Investing.com - Investing.com India

Apr 11, 2025
pulisher
Apr 11, 2025

Rallybio (NASDAQ:RLYB) Cut to Hold at Citizens Jmp - Defense World

Apr 11, 2025
pulisher
Apr 09, 2025

RLYB Ends Pregnancy-Related Rare Disease Program, Stock Tanks - Yahoo Finance

Apr 09, 2025

Rallybio Corp Azioni (RLYB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.61
price up icon 0.78%
$36.03
price up icon 0.39%
$21.65
price up icon 1.34%
$105.24
price up icon 0.02%
$104.98
price up icon 0.19%
biotechnology ONC
$264.93
price down icon 1.26%
Capitalizzazione:     |  Volume (24 ore):